Nexus Pharmaceuticals

We’ve been able to leverage our regulatory expertise to obtain six FDA approvals, with four products being the first generics approved. As a privately owned company, Nexus Pharmaceuticals is headquartered in Vernon Hills, Illinois, a suburb of Chicago.

  • 2003 Nexus Pharmaceuticals was founded in 2003 with the mission of providing safe, high-quality generic drugs that are affordable and accessible to those who need them.
  • 2006 Product Release: Ciprofloxacin Ophthalmic Solution, USP (Brand name: Ciloxan®)
  • 2007 Product Release: Diclofenac Sodium Ophthalmic Solution (Brand name: Voltaren®)
  • 2009 Product Release: Benztropine Mesylate (Brand Name Cogentin®)
  • 2010 Product Release: Levofloxacin Ophthalmic Solution, USP, (Brand name: Quixin®)
  • 2010 Product Release: Levetiracetam Injection (Brand name Keppra®)
  • 2011 In 2011, Nexus Pharmaceuticals opened up a 5,000 square foot research and development lab in Mundelein, Illinois, a short distance from the company’s headquarters.
  • 2012 Product Release: Tranexamic Acid (Brand name Cyclokapron®)

A commitment to providing safe, affordable generic medicines.